Paper36795776
Neuropathology-based APOE genetic risk score better quantifies Alzheimer's risk.
Deming Y and 20 others. Alzheimers Dement, 2023. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Neuropathology-based APOE genetic risk score better quantifies Alzheimer's risk. Papers, record 36795776. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36795776
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Humans | |
| Amyloid beta-Peptides | |
| Apolipoprotein E4 | |
| Apolipoproteins E | |
| Genotype | |
| Risk Factors | |
| tau Proteins |
Source PubMed
Grants18
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AG037639 | NIA NIH HHS | United States | R01AG037639 | PubMed and NIH | NIH RePORTER |
| RF1 AG054047 | NIA NIH HHS | United States | R01AG054047 | PubMed and NIH | NIH RePORTER |
| UL1 TR000427 | NCATS NIH HHS | United States | UL1TR000427 | PubMed and NIH | NIH RePORTER |
| U01 AG024904 | NIA NIH HHS | United States | U01AG024904 | PubMed and NIH | NIH RePORTER |
| S10 OD025245 | NIH HHS | United States | S10OD025245 | PubMed and NIH | NIH RePORTER |
| U19 AG024904 | NIA NIH HHS | United States | U01AG024904 | PubMed and NIH | NIH RePORTER |
| T32 AG000213 | NIA NIH HHS | United States | T32AG000213 | PubMed and NIH | NIH RePORTER |
| UL1 TR002373 | NCATS NIH HHS | United States | UL1TR002373 | PubMed | NIH RePORTER |
| L30 AG069155 | NIA NIH HHS | United States | L30AG069155 | PubMed and NIH | NIH RePORTER |
| P30 AG062715 | NIA NIH HHS | United States | P30AG062715 | PubMed and NIH | NIH RePORTER |
| P50 AG033514 | NIA NIH HHS | United States | P50AG033514 | PubMed and NIH | NIH RePORTER |
| R01 AG070883 | NIA NIH HHS | United States | R01AG070883 | PubMed | NIH RePORTER |
| R01 AG027161 | NIA NIH HHS | United States | R01AG027161 | PubMed and NIH | NIH RePORTER |
| R01 AG054047 | NIA NIH HHS | United States | R01AG054047 | PubMed and NIH | NIH RePORTER |
| R01 AG068398 | NIA NIH HHS | United States | R01AG068398 | PubMed and NIH | NIH RePORTER |
| T32 AG000129 | NIA NIH HHS | United States | T32AG000129 | PubMed and NIH | NIH RePORTER |
| R01 AG021155 | NIA NIH HHS | United States | R01AG021155 | PubMed and NIH | NIH RePORTER |
| RF1AG054047 | NIH | NIH RePORTER |
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23364031 | Apolipoprotein E and change in episodic memory in blacks and whites. | Neuroepidemiology | 2013 | https://conductscience.org/library/papers/23364031 | PubMed |
| 2 | 26555316 | Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid. | Alzheimers Dement | 2016 | https://conductscience.org/library/papers/26555316 | PubMed |
| 3 | 27042676 | CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease. | Ann Clin Transl Neurol | 2016 | https://conductscience.org/library/papers/27042676 | PubMed |
| 4 | 11816784 | Pathologic correlates of nondemented aging, mild cognitive impairment, and early-stage Alzheimer's disease. | J Mol Neurosci | 2001 | https://conductscience.org/library/papers/11816784 | PubMed |
| 5 | 35139894 | A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease. | Alzheimers Res Ther | 2022 | https://conductscience.org/library/papers/35139894 | PubMed |
| 6 | 35061102 | Don't forget about tau: the effects of ApoE4 genotype on Alzheimer's disease cerebrospinal fluid biomarkers in subjects with mild cognitive impairment-data from the Dementia Competence Network. | J Neural Transm (Vienna) | 2022 | https://conductscience.org/library/papers/35061102 | PubMed |
| 7 | 18525196 | Racial differences in the influence of the APOE epsilon 4 allele on cognitive decline in a sample of community-dwelling older adults. | Gerontology | 2009 | https://conductscience.org/library/papers/18525196 | PubMed |
| 8 | 31834392 | Racial Disparity in Cerebrospinal Fluid Amyloid and Tau Biomarkers and Associated Cutoffs for Mild Cognitive Impairment. | JAMA Netw Open | 2019 | https://conductscience.org/library/papers/31834392 | PubMed |
| 9 | 19260027 | Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly. | Ann Neurol | 2009 | https://conductscience.org/library/papers/19260027 | PubMed |
| 10 | 28247064 | Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers. | Acta Neuropathol | 2017 | https://conductscience.org/library/papers/28247064 | PubMed |
| 11 | 31010420 | Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease. | Alzheimers Res Ther | 2019 | https://conductscience.org/library/papers/31010420 | PubMed |
| 12 | 23419830 | CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4. | Mol Psychiatry | 2014 | https://conductscience.org/library/papers/23419830 | PubMed |
| 13 | 31836810 | Predicting clinical decline and conversion to Alzheimer's disease or dementia using novel Elecsys Aβ(1-42), pTau and tTau CSF immunoassays. | Sci Rep | 2019 | https://conductscience.org/library/papers/31836810 | PubMed |
| 14 | 17012293 | CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer's disease. | Brain | 2006 | https://conductscience.org/library/papers/17012293 | PubMed |
| 15 | 35473631 | The cerebrospinal fluid biomarker ratio Aβ42/40 identifies amyloid positron emission tomography positivity better than Aβ42 alone in a heterogeneous memory clinic cohort. | Alzheimers Res Ther | 2022 | https://conductscience.org/library/papers/35473631 | PubMed |
| 16 | 29322089 | The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions. | Alzheimers Dement (Amst) | 2018 | https://conductscience.org/library/papers/29322089 | PubMed |
| 17 | 29499171 | CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts. | Alzheimers Dement | 2018 | https://conductscience.org/library/papers/29499171 | PubMed |
| 18 | 35142437 | APOE genotype, hippocampus, and cognitive markers of Alzheimer's disease in American Indians: Data from the Strong Heart Study. | Alzheimers Dement | 2022 | https://conductscience.org/library/papers/35142437 | PubMed |
| 19 | 30321505 | Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative. | Alzheimers Dement | 2019 | https://conductscience.org/library/papers/30321505 | PubMed |
| 20 | 31561363 | Race, APOEɛ4, and Long-Term Cognitive Trajectories in a Biracial Population Sample. | J Alzheimers Dis | 2019 | https://conductscience.org/library/papers/31561363 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42758029 | Multi-omics integration of transcriptomics and metabolomics with machine learning uncovers novel risk factors for Alzheimer's disease. | J Alzheimers Dis | 2026 | https://conductscience.org/library/papers/42758029 | PubMed |
| 42226250 | Unraveling 'F' factor: towards a genetic-clinical framework for the musculoskeletal-heart crosstalk in metabolic aging. | Cardiovasc Diabetol | 2026 | https://conductscience.org/library/papers/42226250 | PubMed |
| 41988903 | Clinical impact of the Alzheimer's Disease Neuroimaging Initiative: A review of studies using ADNI data (2023 to June 2025). | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/41988903 | PubMed |
| 41741571 | Integrated transcriptomic analysis of the temporal cortex identifies CRH and GAD2 as neuropathological markers and reveals altered immune microenvironment in Alzheimer's disease. | Sci Rep | 2026 | https://conductscience.org/library/papers/41741571 | PubMed |
| 41537452 | Early-life influences on the risk for later-life Alzheimer's and non-Alzheimer's dementia: A nearly full life course prospective cohort study. | Alzheimers Dement | 2026 | https://conductscience.org/library/papers/41537452 | PubMed |
| 41201456 | Integrative analysis of cerebrospinal fluid biomarkers, metabolomics, and polygenic risk reveals novel metabolite associations with Alzheimer's disease. | J Alzheimers Dis | 2025 | https://conductscience.org/library/papers/41201456 | PubMed |
| 41097067 | Preexisting Genetic Background Primes the Responses of Human Neurons to Amyloid β. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41097067 | PubMed |
| 41074912 | APOE ε4 linked effects on clinical features and neuropathology in dementia with Lewy bodies. | Alzheimers Dement | 2025 | https://conductscience.org/library/papers/41074912 | PubMed |
| 41004623 | Targeted serum metabolomic profiling and machine learning approach in Alzheimer's disease using the Alzheimer's disease diagnostics clinical study (ADDIA) cohort. | J Alzheimers Dis | 2025 | https://conductscience.org/library/papers/41004623 | PubMed |
| 40959270 | Altered Heme and Redox Homeostasis Underpin Late-onset Alzheimer's Disease. | Int J Biol Sci | 2025 | https://conductscience.org/library/papers/40959270 | PubMed |
| 40747112 | Evaluating polygenic risk score prediction performance for Alzheimer's disease in a population-based Hispanic cohort using single- and multi-ancestry models. | Lancet Reg Health Am | 2025 | https://conductscience.org/library/papers/40747112 | PubMed |
| 40710902 | Advances in Genetic Risk Scores for Alzheimer's Disease and Dementia: A Systematic Review. | Neurol Int | 2025 | https://conductscience.org/library/papers/40710902 | PubMed |
| 40093261 | Physical activity and APOE neuropathology score modify the association of age and [11C]-PiB-PET amyloid burden in a cohort enriched with risk for Alzheimer's disease. | medRxiv | 2025 | https://conductscience.org/library/papers/40093261 | PubMed |
| 38970274 | Longitudinal plasma phosphorylated-tau217 and other related biomarkers in a non-demented Alzheimer's risk-enhanced sample. | Alzheimers Dement | 2024 | https://conductscience.org/library/papers/38970274 | PubMed |
| 38049659 | Florbetapir PET-assessed demyelination is associated with faster tau accumulation in an APOE ε4-dependent manner. | Eur J Nucl Med Mol Imaging | 2024 | https://conductscience.org/library/papers/38049659 | PubMed |
| 37482996 | Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals. | J Alzheimers Dis | 2023 | https://conductscience.org/library/papers/37482996 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APOE | 348 | PubTator's text mining | https://conductscience.org/library/genes/348 | NCBI Gene |
| MAPT | 4137 | PubTator's text mining | https://conductscience.org/library/genes/4137 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36795776
GET https://conductscience.org/api/papers/v1/36795776/authors?page=2